Literature DB >> 29401264

Stretch-induced compliance: a novel adaptive biological mechanism following acute cardiac load.

André M Leite-Moreira1,2, João Almeida-Coelho1, João S Neves1, Ana L Pires1, João Ferreira-Martins1, Ricardo Castro-Ferreira1, Ricardo Ladeiras-Lopes1, Glória Conceição1, Daniela Miranda-Silva1, Patrícia Rodrigues1, Nazha Hamdani3, Melissa Herwig3, Inês Falcão-Pires1, Walter J Paulus4, Wolfgang A Linke5, André P Lourenço1,2, Adelino F Leite-Moreira1,6.   

Abstract

Aims: The heart is constantly challenged with acute bouts of stretching or overload. Systolic adaptations to these challenges are known but adaptations in diastolic stiffness remain unknown. We evaluated adaptations in myocardial stiffness due to acute stretching and characterized the underlying mechanisms. Methods and results: Left ventricles (LVs) of intact rat hearts, rabbit papillary muscles and myocardial strips from cardiac surgery patients were stretched. After stretching, there was a sustained >40% decrease in end-diastolic pressure (EDP) or passive tension (PT) for 15 min in all species and experimental preparations. Stretching by volume loading in volunteers and cardiac surgery patients resulted in E/E' and EDP decreases, respectively, after sustained stretching. Stretched samples had increased myocardial cGMP levels, increased phosphorylated vasodilator-stimulated phosphoprotein phosphorylation, as well as, increased titin phosphorylation, which was reduced by prior protein kinase G (PKG) inhibition (PKGi). Skinned cardiomyocytes from stretched and non-stretched myocardia were studied. Skinned cardiomyocytes from stretched hearts showed decreased PT, which was abrogated by protein phosphatase incubation; whereas those from non-stretched hearts decreased PT after PKG incubation. Pharmacological studies assessed the role of nitric oxide (NO) and natriuretic peptides (NPs). PT decay after stretching was significantly reduced by combined NP antagonism, NO synthase inhibition and NO scavenging, or by PKGi. Response to stretching was remarkably reduced in a rat model of LV hypertrophy, which also failed to increase titin phosphorylation. Conclusions: We describe and translate to human physiology a novel adaptive mechanism, partly mediated by titin phosphorylation through cGMP-PKG signalling, whereby myocardial compliance increases in response to acute stretching. This mechanism may not function in the hypertrophic heart.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29401264     DOI: 10.1093/cvr/cvy026

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  5 in total

1.  Ca2+/calmodulin-dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model.

Authors:  Kamilla Gömöri; Melissa Herwig; Heidi Budde; Roua Hassoun; Nusratul Mostafi; Saltanat Zhazykbayeva; Marcel Sieme; Suvasini Modi; Tamara Szabados; Judit Pipis; Nikolett Farkas-Morvay; István Leprán; Gergely Ágoston; István Baczkó; Árpád Kovács; Andreas Mügge; Péter Ferdinandy; Anikó Görbe; Péter Bencsik; Nazha Hamdani
Journal:  ESC Heart Fail       Date:  2022-05-18

Review 2.  From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.

Authors:  Walter J Paulus; Michael R Zile
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

Review 3.  Posttranslational modifications of titin from cardiac muscle: how, where, and what for?

Authors:  Franziska Koser; Christine Loescher; Wolfgang A Linke
Journal:  FEBS J       Date:  2019-04-29       Impact factor: 5.542

Review 4.  Nitric Oxide and Mechano-Electrical Transduction in Cardiomyocytes.

Authors:  Hannah E Boycott; My-Nhan Nguyen; Besarte Vrellaku; Katja Gehmlich; Paul Robinson
Journal:  Front Physiol       Date:  2020-12-15       Impact factor: 4.566

5.  C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness.

Authors:  Konstanze Michel; Melissa Herwig; Franziska Werner; Katarina Špiranec Spes; Marco Abeßer; Kai Schuh; Swati Dabral; Andreas Mügge; Hideo A Baba; Boris V Skryabin; Nazha Hamdani; Michaela Kuhn
Journal:  JCI Insight       Date:  2020-11-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.